As the leading platform for biopharma regulated digital health solutions, BrightInsight accelerates time to market and ensures compliance for our customers, including Sanofi, Novo Nordisk, Roche, CSL Behring, UCB and others.
Schedule a 1:1 demo of our digital Disease Management Solution
Join our team for San Diego beers and networking in our booth 2637
Monday, June 13, 2022 from 5:00 PM – 6:30 PM PST
The world’s leading biopharma companies trust the BrightInsight Platform for their regulated digital health products including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD).
"We are excited to partner with BrightInsight, strengthening our commitment to addressing unmet needs in the rare disease space, and putting patients at the forefront of our innovations."
Colin Lake, VP, Head of Digital Business Transformation Neurology, UCBPress Release
"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."
Brian Johnson, Director, Digital Health, CSL BehringCase Study
"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."
Anders Dyhr Toft, Corporate Vice President, Commercial Innovation, Novo NordiskLearn More